Amelie Ramirez Wins AACI Cancer Health Equity Award

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Our Hispanic community is a vibrant and essential part of the American tapestry, contributing richly to the country’s society, culture, and economy. Yet, when it comes to healthcare, this community grapples with significant disparities, especially in cancer care.

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Clairity Inc. received FDA De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025—propelling a new era of precision medicine in breast cancer.

June 06, 2025

Vol.51 No.22

In Brief

Abu-Rustum, Burt Nabors, Styler, Thompson receive 2025 NCCN awards

Nadeem R. Abu-RustumLouis Burt NaborsMichael J. StylerJames ThompsonErin HeslerNadeem R. Abu-Rustum, Louis Burt Nabors, Michael J. Styler, and James Thompson were recognized by the National Comprehensive Cancer Network as its 2025 awardees who “go above and beyond to define and advance quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives.”

May 30, 2025

Vol.51 No.21

In Brief

The Cancer Letter’s Jacquelyn Cobb named finalist for NIHCM Trade Journalism Awards

Jacquelyn Cobb, associate editor of The Cancer Letter, was named a finalist for the 31st Annual NIHCM Awards in Research and Journalism for her series, “Multi-cancer detection tests fall short of their promises.”

May 16, 2025

Vol.51 No.19

Funding Opportunities

Maryland Stem Cell Research Fund awards over $18M to drive breakthroughs in regenerative medicine

The Maryland Stem Cell Research Commission awarded over $18 million in grants aimed at accelerating cutting-edge stem cell and regenerative medicine research across Maryland.

May 16, 2025

Vol.51 No.19

Clinical Roundup

Study assesses advancing racial equity in cancer care through multimodal AI

Artera, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, announced the publication of a validation study in the JCO Clinical Cancer Informatics on Artera’s MMAI model.

May 16, 2025

Vol.51 No.19

Amelie Ramirez Wins AACI Cancer Health Equity Award

YOU MAY BE INTERESTED IN

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Abu-Rustum, Burt Nabors, Styler, Thompson receive 2025 NCCN awards

The Cancer Letter’s Jacquelyn Cobb named finalist for NIHCM Trade Journalism Awards

Maryland Stem Cell Research Fund awards over $18M to drive breakthroughs in regenerative medicine

Study assesses advancing racial equity in cancer care through multimodal AI

Renew today!

Subscriber content

Never miss an issue!

Login